Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans

Atherosclerosis

Volumn 124, Issue 2, 1996, Pages 261-271

  Anber, V ^a   Griffin, B A ^a   McConnell, M ^a   Packard, C J ^a   Shepherd, J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Arterial proteoglycans; Atherogenic lipoprotein phenotype; Low density lipoprotein subfractions

Indexed keywords

LIPOPROTEIN; PROTEOGLYCAN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030565005     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05842-X     Document Type: Article

References (52)

1. [1] Srinivasan SR, Vijayagopal P, Dalferes ER, Abatte B, Radhakrishnamurthy B, Berenson GS. Low density lipoprotein retention by aortic tissue, contribution of extracellular matrix. Atherosclerosis 1986;62:201.
2. [2] Bihari-Varga M, Gregely J, Gero S. Further investigation on complex formation in-vitro between aortic mucopolysaccharides and beta-lipoproteins. J Atheroscler Res 1964;4:106.
3. [3] Bihari-Varga M, Camejo G, Horn MC, Lopez F, Gruber E. Structure of low density lipoprotein in complexes formed with arterial matrix components. Int J Biol Macromol 1983;5:59.
4. [4] Camejo G. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. Adv lipid Res 1982;19:1.
5. [5] Srinivasan SR, Lopez SA, Radhakrishnamurthy B, Berenson GS. Complexing of pre-B and B-lipoprotein and acid mucopolysaccharide. Atherosclerosis 1970;12:321.
6. [6] Srinivasan SR, Yost C, Bandaru RR, Radhakrishnamurthy B, Berenson GS. Lipoprotein-glycosaminoglycan interaction in aortas of rabbits fed atherogenic diets containing different fats. Atherosclerosis 1982;43:289.
7. [7] Berenson GS, Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P, Dalferes ER, Sharma C. Carbohydrate-protein macromolecules and arterial integrity, a role in atherogenesis. Exp Mol Pathol 1984;41:267.
8. [8] Wight TN. Vessel proteoglycans and thrombogenesis. Prog Haemostasis Thromb 1980;5:1.
9. [9] Camejo G, Camejo EH, Olsson U, Bonjers G. Proteoglycans and lipoproteins in atherosclerosis. Curr Opin Lipidol 1993;4:385.
10. [10] Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol fed rabbits. I. Focal increases in arterial LDL concentrations precede development of fatty streak lesions. Atherosclerosis 1989;9:895.
11. [11] Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol fed rabbits. I. Selective retention of LDL vs. selective increase in LDL permeability in susceptible sites of arteries. Atherosclerosis 1989;9:908.
12. [12] Srinivasan SR, Radhakrishnamurthy B, Vijayagopal P, Berenson GS. Proteoglycans, Lipoproteins and Atherosclerosis. In: Malmendier CL et al. (eds). Hypercholestrolemia, Hypocholestrolemia, Hypertriglyceridemia. New York: Plenum Press, 1990.
13. [13] Wight TN. Cell biology of arterial proteoglycans. Atherosclerosis 1989;9:1,1.
14. [14] Srinivasan SR, Vijayagopal P, Ebrele K, Radhakrishnamurthy B, Berenson GS. Low density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulphate proteoglycan subfraction. Biochim Biophys Acta 1989;1006:159.
15. [15] Bihari-Varga M, Gruber E, Rotheneder M, Zechner R. Kostner GM. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1988;8:851.
16. [16] Berenson GS, Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P. Arterial wall proteoglycans - biologic properties related to pathogenesis of atherosclerosis. Elsevier Science Publishers B.V. (Biomedical Division). Atherosclerosis 1986; VII N.H. Fidge and Nestel editors.
17. [17] Srinivasan SR, Vijayagopal P, Dalferes ER Jr., Abbat B, Radhakrishnamurthy B, Berenson GS. Dynamics of lipoprotein-glycosaminoglycan interactions in the atherosclerotic rabbit aorta in-vivo. Biochim Biophys Acta 1984;793:157.
18. [18] Mawhinney TP, Augustyn JM, Fritz KE. Glycosaminoglycan - lipoprotein complexes from aortas of hypercholestrolemic rabbits. Atherosclerosis 1978;31:155.
19. [19] Camejo G, Eva-Hurt Camejo, Romano M. Properties of lipoprotein complexes isolated by affinity chromatography from human aorta. Biomed Biochem Acta 1985; 44(3):389.
20. [20] Srinivasan SR, Dolan P, Radhakrishnamurthy B, Pargaonkar PS, Berenson GS. Lipoprotein - acid muccopolysacchride complexes of human atherosclerotic lesions. Biochim Biophys Acta 1975;388:58.
21. [21] Hoff HF, Bond MG. Apolipoprotein B localisation in coronary atherosclerotic Plaques from cynomolgus monkeys. Artery 1983;12(2):104.
22. [22] Lark MW, YeoKT, Mar H, et al. Arterial chondroitin sulphate proteoglycan: localisation with monoclonal antibody. J Histochem Cytochem 1988;86:1221.
23. [23] Camejo G, Acquatela H, Lalaguna F. The interaction of low density lipoprotein with arterial proteoglycans: an additional risk factor? Atherosclerosis 1980;36:55.
24. [24] Kempen HJM, Buytenhek M, Gruber E, Bihari-Varga M. Factor, present in plasma, inhibiting the interaction of low density lipoprotein with arterial proteoglycan. Atherosclerosis 1989;78:137.
25. [25] Steele RH, Wagner WD. Lipoprotein interaction with artery wall derived proteoglycan: comparison between atherosclerosis susceptible W-2 pigeons and Show Racer pigeons. Atherosclerosis 1987;65:63.
26. [26] Sambandam T, Baker JR, Christner JE, Ekborg SL. Specificity of low density lipoprotein-glycosaminoglycan interaction. Arterioscler Thromb 1991;11:561.
27. [27] Linden T, Bondjers G, Camejo G, Bergstran R, Wilhelmsen L, Wiklund O. Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction. Eur J Clin Invest 1989;19:38.
28. [29] Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low density lipoprotein subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 1990;83:59.
29. [30] Austin MA, Breslow JL, Hennekens CH, Burling JE, Willett WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988;260:1917.
30. [31] Griffin BG, Freeman DJ, Tait GW, Caslake MJ, Thomson J, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL): relative contribution of small dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241.
31. [32] Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495.
32. [33] Lipid Research Clinics Program. Manual of Laboratory Operations, Vol. 1, Lipid and Lipoprotein Analysis, National Institutes of Health, Bethesda, Maryland 20014, DHEW Publications (NIH), 1975;75.
33. [34] Watson TDG, Caslake MJ, Freeman DJ, Griffin BA, Packard CJ, Shepherd J. Determinants of low density lipoprotein subfraction distribution and concentrations in normolipidemic subjects. Arteriosclerosis 1994;14:902.
34. [35] Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265.
35. [36] Oegema TRJr., Hascall VC, Eisenstein R. Characterisation of bovine aorta proteoglycan extracted with guanidine hydrachloride in the presence of protease inhibitors. J Biol Chem 1979;254:1312.
36. [37] Salisbury BGJ, Wagner WD. Isolation and preliminary characterisation of proteoglycans dissociatively extracted from human aorta. J Biol Chem 1981;256:8050.
37. [38] Wagner WD, Salisbury BGJ, Rowe HA. A proposed structure of chondroitin-6-sulphate proteoglycan of human normal and adjacent atherosclerotic plaque. Arteriosclerosis 1986;6:407.
38. [39] Hinnie J, Serafini-Fracassini. The proteoglycans of bovine nasal cartilage and human articular cartilage. Sedimentation equilibrium analysis. Biopolymers 1986;25:1095.
39. [40] Waddington RJ, Embery G, Last K. Glycosaminoglycans of human alveolar tissue. Arch Oral Biol 1989;34(7):587.
40. [41] Camejo G, Lopez A, Lopez F, Quinones J. Interaction of low density lipoprotein with arterial proteoglycans. The role of charge and sialic acid content. Atherosclerosis 1985;55:93.
41. [42] Camejo G, Linden T, Olsson U, Wiklund O, Lopez F, Bondjers G. Binding parameters and concentration modulate formation of complexes between LDL and arterial proteoglycans in serum. Atherosclerosis 1989;79:121.
42. [43] Kapoor R, Phelps CF, Coster L, Franson LA. Bovine aortic chondroitin sulphate-dermatan sulphate containing proteoglycans. Biochem J 1981;197:259.
43. [44] Olsson U, Camejo G, Bonjers G. Binding of a synthetic lipoprotein B-100 peptide and peptide analogues to chondroitin-6-sulfate: Effects of lipid enviroment. Biochemistry 1993;32:1858.
44. [45] Alves CS, Mourao AS. Interaction of high molecular weight chondroitin sulphate from human aorta with plasma low density lipoprotein. Atherosclerosis 1988;73:113.
45. [46] Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Wiklund O, Bondjers G. Differential uptake of proteoglycan selected subfractions of low density lipoprotein by human macrophages. J Lip Res 1990;31:1387.
46. [47] Labat-Robert J, Gruber E, Bihari-Varga M. Interaction between fibronectin, proteoglycan and lipoprotein. Int J Biol 1990;12:50.
47. [48] Reaven GM, Ida Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance in hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993;92:141.
48. [49] Camejo G, Cortez MM, Lopez F, Starosta R, Mosquera B, Socorro L. Factors modulating the interaction of LDL with an arterial lipoprotein complexing proteoglycan: The effect of HDL. Acta Med Scand (Suppl) 1980;642:159.
49. [50] De Graaf J, Hak-Lemers HLM, Hectors MPC, Demaker PNM, Hendriks JCM, Stalenhoef AFH. Inhanced susceptibility to in-vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991;11:298.
50. [51] Linden T, Camejo G, Wiklund O, Wornold I, Olofsson SO, Bondjers G. Effect of short-term β-blockade on serum lipid levels and on the interaction of LDL with human arterial proteoglycans. J Clin Pharmacol 1990;30:S124.
51. [52] Kinoshita M, Krul ES, Schonfeld G. Modification of the core lipid of low density lipoproteins produces selective alterations in the expression of apo-B epitopes. J Lipid Res 1990;31:701.
52. [53] Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Thanh-Dung Ngu'Yen, Gleeson A, Arad Y, Witte L, Al-Haider M, Rumsey SC, Deckelbaum RJ. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglycride-rich LDL of normal size. J Biol Chem 1994;269(1):511.